Physical wastage of immunobiological products in the state of Ceará, Brazil, 2014-2016. / Perdas físicas de imunobiológicos no estado do Ceará, 2014-2016.

OBJECTIVE: to describe discarded wasted immunobiological products provided by the National Im-munization Program (PNI) to the State of Ceará between 2014 and 2016, and the costs of discarded doses. METHODS: this was a descriptive study using data from suspect im-munobiological product evaluation forms and data from disposal approval forms. RESULTS: a total of 317 forms were included, 72.0% of which had a disposal approval form, and 160,767 discarded doses were identified, at a total cost of BRL 1,834,604.75; wastage accounted for 0.45%, 0.93% and 0.53% of the total cost of vaccines in 2014, 2015 and 2016, respectively; the main reason for the wastage identified was electric power shortage (54.9%). CONCLUSION: we identified a large number of discarded wasted doses, with high absolute cost; tighter control is necessary, as failures in conservation dynamics may interfere with the supply of immunobiologicals.

Perdas físicas de imunobiológicos no estado do Ceará, 2014-2016 / Pérdidas físicas de inmunobiológicos en el estado de Ceará, Brasil, 2014-2016 / Physical wastage of immunobiological products in the state of Ceará, Brazil, 2014-2016

Objetivo: descrever as perdas físicas, por descarte, dos imunobiológicos fornecidos pelo Programa Nacional de Imunizações (PNI) ao estado do Ceará no período 2014-2016, e os custos das doses perdidas. Métodos: estudo descritivo, com dados dos formulários de avaliação de imunobiológicos sob suspeita e dos pareceres favoráveis de descarte. Resultados: foram incluídos 317 formulários, dos quais 72,0% obtiveram parecer de descarte; foram identificadas 160.767 doses perdidas, totalizando um custo de R$ 1.834.604,75; as perdas representaram 0,45%, 0,93% e 0,53% do custo total das vacinas nos anos de 2014, 2015 e 2016, respectivamente; o principal motivo das perdas físicas identificadas foi a falta de energia elétrica (54,9%). Conclusão: identificou-se grande número de doses descartadas por perdas físicas, com elevado custo absoluto; faz-se necessário um controle mais rigoroso, pois falhas na dinâmica de conservação podem interferir na oferta dos imunobiológicos.

Objetivo: describir las pérdidas físicas por eliminación de inmunobiológicos proporcionados por el Programa Nacional de Inmunización (PNI) al estado de Ceará, en el periodo 2014-2016, y los costos de las dosis omitidas. Métodos: estudio descriptivo, con datos de formula-rios de evaluación de los inmunobiológicos sospechosos y de las opiniones favorables de descarte. Resultados: se incluyeron un total de 317 formularios, de los cuales el 72,0% obtuvo una opinión de descarte, y se identificaron 160.767 dosis omitidas, con un costo total de R$ 1.834.604,75; las pérdidas representaron el 0,45%, el 0,93% y el 0,53% del costo total de las vacunas en 2014, 2015 y 2016, respectivamente; la razón principal de las pérdidas físicas identificadas fue la falta de electricidad (54,9%). Conclusión: iden-tificamos un gran número de dosis descartadas por pérdidas físicas, con un alto costo absoluto; es necesario un control más estricto, ya que las fallas en la dinámica de conser-vación pueden interferir con el suministro de inmunobiológicos.

Objective: to describe discarded wasted immunobiological products provided by the National Im-munization Program (PNI) to the State of Ceará between 2014 and 2016, and the costs of discarded doses. Methods: this was a descriptive study using data from suspect im-munobiological product evaluation forms and data from disposal approval forms. Results: a total of 317 forms were included, 72.0% of which had a disposal approval form, and 160,767 discarded doses were identified, at a total cost of BRL 1,834,604.75; wastage accounted for 0.45%, 0.93% and 0.53% of the total cost of vaccines in 2014, 2015 and 2016, respectively; the main reason for the wastage identified was electric power shortage (54.9%). Conclusion: we identified a large number of discarded wasted doses, with high absolute cost; tighter control is necessary, as failures in conservation dynamics may interfere with the supply of immunobiologicals.